Tag Archives: submit-news
Innovnano’s New Ceramic Powder Offers an Improved Alternative to 3YSZ for Structural Ceramic Applications
Innovnano’s 2YSZ combines enhanced fracture toughness with high stability and ageing resistance. In an exciting development for the structural ceramics market, Innovnano, a European…
Fluorescent markers could jumpstart U.K. recycling
Brunel University London develops a set of invisible phosphor inks that can be coated onto labels and detected by UV to speed the sorting of plastics during recycling.
The forecast for global bioplastics
A new report shows that while the current market for bioplastics for packaging accounts for only a small share of the global plastic packaging market value, it is growing rapidly.
TEKLYNX reports labeling improvements for LSI Industries
The LSI Lighting Division has reduced ongoing file maintenance by 80% and eliminated 6,000 static label files.
NXP Sells Stake in China Foundry ASMC
NXP Semiconductors NV said Wednesday (April 19) it sold its 27 percent remaining stake in Advanced Semiconductor Manufacturing Corp. Ltd.
Eaglewood Technologies selects APR to represent Laserlox and Sanilox Systems in the US
The recently introduced Laserlox system was developed specifically for the flexible packaging and label printing industries.
Kodak Breaks Ground on Flexo Manufacturing Facility Expansion
Kodak hosted customers and community leaders at an April 20 groundbreaking ceremony in Weatherford, Okla. to celebrate the expansion of its manufacturing facility in the area
New Blockchain Research Firm Publishes Debut eBook: Blockchain Meets Supply Chain
Book is a primer for those who want to learn about blockchain basics and potential applications in supply chain management.
‘Bigger purpose’ valued at International Plastics
When it comes to the core values of International Plastics Inc., it all boils down to the acronym PRACTICE: People, Respect, Attitude, Commitment, Teamwork, Integrity, Customers and Excellence.
Allergan, Novartis Partner on NASH Program
The collaboration is focused on Phase 2b clinical trial to evaluate use of Allergan’s Cenicriviroc and Novartis lead FXR agonist to treat non-alcoholic steatohepatitis.